CXCR2 and ovarian carcinoma: The overexpression of CXCR2 in tumor cells can lead to ovarian cancer progression by enhancing NF-κB activation via EGFR-transactivated Akt signaling, thereby upregulating the expression of pro-inflammatory chemokines [35].